Skip to main content
Fig. 6 | Cancer Nanotechnology

Fig. 6

From: Folic acid-functionalized PEGylated niosomes co-encapsulated cisplatin and doxoribicin exhibit enhanced anticancer efficacy

Fig. 6

A Quantitative apoptosis analysis of A2780 cells after treatment with IC50 concentration of empty niosomes (N), DOX + CIS, DOX + CIS-Nio, and DOX + CIS-Nio@PEG–FA; B quantitative apoptosis analysis of MCF7 cells after treatment with IC50 concentration of empty niosomes (N), DOX + CIS, DOX + CIS-Nio, and DOX + CIS-Nio@PEG–FA. The upper left square (Q1) shows the percentage of necrotic cells and the upper right square (Q2) exhibits the percentage of late apoptotic cells, (Q3) exhibits the percentage of early apoptotic cells, and (Q4) shows the percentage of live cells. The data presented means the standard deviation (n = 3). For all graphs, ****P < 0.0001, **P < 0.01. The control sample refers to the cells without treatment

Back to article page